Synergy Chc EPS Jumps 86 Percent in Q2
Synergy Chc (NASDAQ:SNYR), a health and wellness products company known for its brain health and nutritional supplement brands, released its second quarter 2025 results on August 14, 2025. The most notable headline was an 86% rise in earnings per share (GAAP) to $0.17, well above analyst expectations of $0.08 (GAAP). However, revenue (GAAP) was just $8.13 million, falling 25.0% short of forecasts (GAAP revenue) and rising only slightly from the prior year. Net income (GAAP) more than doubled compared to the same period in 2024, while record gross margins and significant licensing revenue contributed to profits. Despite continued profitability, the quarter revealed execution risks in scaling distribution and highlighted reliance on one-off-like license income. Overall, the period marked a tenth consecutive quarter of profitability but with underlying sales concerns.
Source: Analyst estimates for the quarter provided by FactSet.
Synergy Chc markets and distributes brain health and wellness supplements in the U.S. and internationally. Its main products include FOCUSfactor, a supplement used to support memory and concentration, and Flat Tummy, a nutritional solution brand for women’s wellness. These products target segments with robust growth, such as the brain health supplements market and global weight management programs.
Source Fool.com
